169 related articles for article (PubMed ID: 38277301)
1. Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation.
Lu QL; Holbrook MC; Cataldi MP; Blaeser A
J Neuromuscul Dis; 2024; 11(2):275-284. PubMed ID: 38277301
[TBL] [Abstract][Full Text] [Related]
2. Fukutin-Related Protein: From Pathology to Treatments.
Ortiz-Cordero C; Azzag K; Perlingeiro RCR
Trends Cell Biol; 2021 Mar; 31(3):197-210. PubMed ID: 33272829
[TBL] [Abstract][Full Text] [Related]
3. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
4. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.
Dhoke NR; Kim H; Selvaraj S; Azzag K; Zhou H; Oliveira NAJ; Tungtur S; Ortiz-Cordero C; Kiley J; Lu QL; Bang AG; Perlingeiro RCR
Cell Rep; 2021 Jul; 36(2):109360. PubMed ID: 34260922
[TBL] [Abstract][Full Text] [Related]
5. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.
Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC
Elife; 2021 Jan; 10():. PubMed ID: 33513091
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
[TBL] [Abstract][Full Text] [Related]
7. Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.
Lu QL
J Neuromuscul Dis; 2021; 8(s2):S359-S367. PubMed ID: 34151854
[TBL] [Abstract][Full Text] [Related]
8. Prenatal muscle development in a mouse model for the secondary dystroglycanopathies.
Kim J; Hopkinson M; Kavishwar M; Fernandez-Fuente M; Brown SC
Skelet Muscle; 2016; 6():3. PubMed ID: 26900448
[TBL] [Abstract][Full Text] [Related]
9. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.
Wu B; Drains M; Shah SN; Lu PJ; Leroy V; Killilee J; Rawls R; Tucker JD; Blaeser A; Lu QL
PLoS One; 2022; 17(12):e0278482. PubMed ID: 36454905
[TBL] [Abstract][Full Text] [Related]
10. A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.
Kim J; Lana B; Torelli S; Ryan D; Catapano F; Ala P; Luft C; Stevens E; Konstantinidis E; Louzada S; Fu B; Paredes-Redondo A; Chan AE; Yang F; Stemple DL; Liu P; Ketteler R; Selwood DL; Muntoni F; Lin YY
EMBO Rep; 2019 Nov; 20(11):e47967. PubMed ID: 31566294
[TBL] [Abstract][Full Text] [Related]
11. Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I.
Cataldi MP; Vannoy CH; Blaeser A; Tucker JD; Leroy V; Rawls R; Killilee J; Holbrook MC; Lu QL
Mol Ther; 2023 Dec; 31(12):3478-3489. PubMed ID: 37919902
[TBL] [Abstract][Full Text] [Related]
12. NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
Bailey EC; Alrowaished SS; Kilroy EA; Crooks ES; Drinkert DM; Karunasiri CM; Belanger JJ; Khalil A; Kelley JB; Henry CA
Skelet Muscle; 2019 Aug; 9(1):21. PubMed ID: 31391079
[TBL] [Abstract][Full Text] [Related]
13. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
[TBL] [Abstract][Full Text] [Related]
14. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
15. Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration.
Awano H; Blaeser A; Keramaris E; Xu L; Tucker J; Wu B; Lu P; Lu QL
Am J Pathol; 2015 Jul; 185(7):2025-37. PubMed ID: 25976249
[TBL] [Abstract][Full Text] [Related]
16. Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice.
Keramaris E; Lu PJ; Tucker J; Lu QL
Muscle Nerve; 2017 Apr; 55(4):582-590. PubMed ID: 27515093
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.
Blaeser A; Keramaris E; Chan YM; Sparks S; Cowley D; Xiao X; Lu QL
Hum Genet; 2013 Aug; 132(8):923-34. PubMed ID: 23591631
[TBL] [Abstract][Full Text] [Related]
18. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.
Awano H; Blaeser A; Wu B; Lu P; Keramaris-Vrantsis E; Lu Q
Neuromuscul Disord; 2015 Jun; 25(6):474-84. PubMed ID: 25937147
[TBL] [Abstract][Full Text] [Related]
19. FKRP directed fibronectin glycosylation: A novel mechanism giving insights into muscular dystrophies?
Boyd A; Montandon M; Wood AJ; Currie PD
Bioessays; 2022 May; 44(5):e2100270. PubMed ID: 35229908
[TBL] [Abstract][Full Text] [Related]
20. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]